Pimitespib, an HSP90 inhibitor, augments nifuroxazide-induced disruption in the IL-6/STAT3/HIF-1α autocrine loop in rats with bleomycin-challenged lungs: Evolutionary perspective in managing pulmonary fibrosis-Reference-Cited by-同舟云学术

Pimitespib, an HSP90 inhibitor, augments nifuroxazide-induced disruption in the IL-6/STAT3/HIF-1α autocrine loop in rats with bleomycin-challenged lungs: Evolutionary perspective in managing pulmonary fibrosis

Published:2022-09 Issue: Volume:153 Page:113487
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

El-Kashef Dalia H.,Youssef Mahmoud E.,Nasr Mohamed,Alrouji Mohammed,Alhajlah Sharif,AlOmeir Othman,El Adle Khalaf Noura,Ghaffar Dalia M. Abdel,Jamil Lubna,Abdel-Nasser Zeinab M.,Ibrahim Samar,Abdeldaiem Mahmoud Said Ibrahim,Donia Sally S.,Mohammed Osama A.,Morsy Nesreen Elsayed,Shata Ahmed,Saber Sameh

Funder

Shaqra University

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference79 articles.

1. Idiopathic pulmonary fibrosis;Gross;New Engl. J. Med.,2001

2. The dynamic interplay between AMPK/NFκB signaling and NLRP3 is a new therapeutic target in inflammation: Emerging role of dapagliflozin in overcoming lipopolysaccharide-mediated lung injury;Abd El-Fattah;Biomed. Pharmacother.,2022

3. 5-HT7 receptor antagonism (SB-269970) attenuates bleomycin-induced pulmonary fibrosis in rats via downregulating oxidative burden and inflammatory cascades and ameliorating collagen deposition: Comparison to terguride;Tawfik;Eur. J. Pharmacol.,2017

4. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy;Selman;Ann. Intern. Med.,2001

5. Nicorandil ameliorates bleomycin-induced pulmonary fibrosis in rats through modulating eNOS, iNOS, TXNIP and HIF-1α levels;Kseibati;Life Sci.,2020

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulating the HSP90 control over NFκB/NLRP3/Caspase-1 axis is a new therapeutic target in the management of liver fibrosis: Insights into the role of TAS-116 (Pimitespib);Life Sciences;2024-10

2. Comprehensive review of potential drugs with anti-pulmonary fibrosis properties;Biomedicine & Pharmacotherapy;2024-04

3. Prevention of bleomycin-induced pulmonary fibrosis by vaccination with the Tocilizumab mimotope;Human Vaccines & Immunotherapeutics;2024-02-26

4. Itraconazole halts hepatocellular carcinoma progression by modulating sonic hedgehog signaling in rats: A novel therapeutic approach;Pathology - Research and Practice;2024-01

5. From strings to signals: Unraveling the impact of miRNAs on diagnosis, and progression of colorectal cancer;Pathology - Research and Practice;2023-11